Today on Outsourcing-Pharma.com   Pfizer's cost-cutting focus no 'Kindler surprise' Pfizer not alone in feeling the heat of California fires J&J, Galapagos sign deal to search for arthritis 'Holy Grail' Global pact to fight fakes eClinical news in brief

Related Industry News   Merck KGaA pulls out of diabetes research Inhalers failing asthmatics WHO flu vaccine forecast an underestimate Beer goes flat for Kirin, splashes cash on 'ultimate cancer warrior' instead

Breaking News on Outsourcing Pharma
Daily  Wednesday 24 October 2007		Forward to a colleague

	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here Access Full Stories Pfizer's cost-cutting focus no 'Kindler surprise' As it faces an increasingly uncertain financial future, Pfizer's reaffirmation that it plans to retain its focus on cutting costs, including outsourcing and offshoring, comes as no 'Kindler surprise', unlike the... Read Pfizer not alone in feeling the heat of California fires As the fires in California continue to rage, Pfizer and other pharma and biotech companies all over Southern California are bracing themselves for closures and even evacuations of their facilities... Read J&J, Galapagos sign deal to search for arthritis 'Holy Grail' Belgian biotech Galapagos has penned 'by far' its biggest ever deal, with Johnson & Johnson (J&J) committing an estimated €1bn to a joint arthritis research programme... Read Global pact to fight fakes A major new trade agreement aiming to combat counterfeiting has been proposed by representatives of a number of key markets, including the US, EU and several other countries worldwide... Read eClinical news in brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Medidata, Clinphone, Phlexglobal and Octagon Research Solutions... Read
	All News Headlines for: October | September | August
	Related Industry News Merck KGaA pulls out of diabetes research In a shock announcement at its third quarter financial results, Merck KGaA has said it will stop its diabetes research and partner out any current programmes... Read Inhalers failing asthmatics Complicated inhaler devices are failing patients according to a recent report, with tricky mechanisms and techniques resulting in low drug delivery and poor disease management... Read WHO flu vaccine forecast an underestimate The forecast that 4.5 billion doses of pandemic influenza vaccine could be produced by 2010 is an underestimate, according to GlaxoSmithKline... Read Beer goes flat for Kirin, splashes cash on 'ultimate cancer warrior' instead Japan's Kirin Holdings, best-known in the West as a beer maker, will acquire a controlling stake in Kyowa Hakko, and thus get its hands on what Kyowa claims are 'the ultimate antibody warriors' against cancer... Read Weekly Comment 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read Previous Headlines Inhaled insulin: make or break? Eli Lilly is remaining optimistic about its yet-to-be-approved inhaled insulin despite the dramatic downfall of Pfizer's Exubera. But is Exubera's fall from grace an indication of things to come for inhaled diabetes... Read Icon living up to its name Icon is living up to its name, according to a recent contract research organisation (CRO) survey, which also recognised Quintiles and PPD in terms of quality performance... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving Cato Research, Genoway, Caliper Life Sciences and Rules-Based Medicine... Read Inyx Pharma gets new life; Ashton awaits fate Inyx Pharma has been given a new lease on life after it was bought by another UK firm, finally bringing relief after it was dragged into administration when its US parent company Inyx Inc. ran aground financially... Read Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com